Spruce Biosciences earnings were -$51.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SPRB earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$16.2M, up 32.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SPRB reported annual earnings of -$39.0M, with -26.5% growth. The next SPRB earnings date is Nov 9, 2026.
What were Spruce Biosciences's earnings last quarter?
On SPRB's earnings call on Aug 13, 2026, Spruce Biosciences (NASDAQ: SPRB) reported Q2 2026 earnings per share (EPS) of -$6.68, up 90.86% year over year. Total SPRB earnings for the quarter were -$16.23 million. In the same quarter last year, Spruce Biosciences's earnings per share (EPS) was -$3.50.
The next SPRB earnings date is Nov 9, 2026. Add SPRB to your watchlist to be reminded of Spruce Biosciences's next earnings date.
Is Spruce Biosciences profitable or losing money?
As of the last Spruce Biosciences earnings report, Spruce Biosciences is currently losing money. Spruce Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$51.35 million, a 6.24% increase year over year.
What was SPRB's earnings growth in the past year?
As of Spruce Biosciences's earnings date in Aug 13, 2026, Spruce Biosciences's earnings has grown year over year. SPRB earnings in the past year totalled -$51.35 million.
What are Spruce Biosciences's earnings expectations?
The current EPS estimate for Spruce Biosciences's earnings report in Nov 9, 2026 is -$5.76.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.